METHODS FOR ENHANCING SKIN TREATMENTS

Abstract

The present invention relates to methods for enhancing the result of a skin treatment for a human patient. In some embodiments, the methods comprise the step of administering a neurotoxin to a skin area designated for the skin treatment. The skin treatment includes the application of a dermatologic agent and/or procedure.

Description

Claims

1. A method for enhancing a skin treatment for a human patient in need thereof, the method comprising the step of administering a neurotoxin to a skin area designated for skin treatment prior to the skin treatment, wherein a dose of neurotoxin administered is calculated by (a) determining a surface area (centimeter square) of the designated skin area, and(b) multiplying the surface area by a unit of neurotoxin that is equivalent to about 1-5 units of botulinum toxin type A,thereby prolonging a treatment result of the skin treatment at the designated skin area.

2. The method of claim 1 wherein the skin treatment comprises administering a dermatologic agent.

3. The method of claim 2 wherein the skin treatment comprises administering a skin filler.

4. The method of claim 2 wherein the dermatologic agent comprises a corticosteroids emollient, wrinkle modifiers, growth factor, moisturizer, peptide, antioxidant, keratolytic agent, retinoid, deoxyribonucleic acid, acne agents, enzymes, ascorbic acid, anticellulite, glycosaminoglycans, hyaluronic acid, crossed linked hyaluronic acid or combination thereof.

5. The method of claim 1 wherein the skin treatment comprises applying a dermatologic procedure.

6. The method of claim 5 wherein the dermatologic procedure comprises a varicose vein treatment, thermage treatment in facial rejuvenation procedures, filler-based treatment, high intensity focused ultrasound treatment, hormonal treatment for facial enhancement, laser treatment for hair removal, laser treatment for facial rejuvenation, tattoo removal treatments, hair removal treatment, microabrasion and dermabrasion therapies, hair loss treatment, DNA facial enhancement treatment, intense pulsed light photo rejuvenation procedures, anesthetic treatment prior to facial enhancement therapies, anticellulite treatment, facial enhancement, aesthetician treatments, massage treatment, physical and occupational therapy, chiropractic procedures, or combination thereof.

7. The method of claim 1 wherein the neurotoxin is a botulinum toxin type A, B, C1, D, E, F or G.

8. The method of claim 1 wherein the neurotoxin is a botulinum toxin type A.

9. The method of claim 1 wherein the neurotoxin is administered intramuscularly, transdermally or subcutaneously.

10. A method for enhancing a skin treatment for a human patient in need thereof, the method comprising the step of administering a neurotoxin toxin to a skin area designated for skin treatment, thereby prolonging the treatment result of the skin treatment at the designated skin area, wherein the skin treatment comprises administering a dermatologic agent comprising a corticosteroids emollient, wrinkle modifiers, growth factor, moisturizer, peptide, antioxidant, keratolytic agent, retinoid, deoxyribonucleic acid, acne agents, enzymes, ascorbic acid, anticellulite, or combination thereof.

11. The method of claim 10 wherein the neurotoxin is a botulinum toxin type A, B, C1, D, E, F or G.

12. The method of claim 10 wherein the neurotoxin is a botulinum toxin type A.

13. The method of claim 10 wherein the neurotoxin is administered intramuscularly, transdermally or subcutaneously.

14. A method for enhancing a skin treatment for a human patient in need thereof, the method comprising the step of administering a botulinum toxin to a skin area designated for skin treatment, thereby prolonging the treatment result of the skin treatment at the designated skin area, wherein the skin treatment comprises a varicose vein treatment, thermage treatment in facial rejuvenation procedures, filler-based treatment, high intensity focused ultrasound treatment, hormonal treatment for facial enhancement, laser treatment for hair removal, laser treatment for facial rejuvenation, tattoo removal treatments, hair removal treatment, microabrasion and dermabrasion therapies, hair loss treatment, DNA facial enhancement treatment, intense pulsed light photo rejuvenation procedures, anesthetic treatment prior to facial enhancement therapies, anticellulite treatment, facial enhancement, aesthetician treatments, massage treatment, physical and occupational therapy, chiropractic procedures, or combination thereof.

15. The method of claim 14 wherein the neurotoxin is a botulinum toxin type A, B, C1, D, E, F or G.

16. The method of claim 14 wherein the neurotoxin is a botulinum toxin type A.

17. The method of claim 14 wherein the neurotoxin is administered intramuscularly, transdermally or subcutaneously.

18. A method for reducing an amount of a dermatologic agent used during treatment of a skin condition in a human patient in need thereof, the method comprising the step of administering a neurotoxin to a skin area designated for skin treatment, thereby reducing the amount of dermatologic agent used to obtain a treatment result at the designated skin area, wherein a higher amount of an identical dermatologic agent is required to obtain the same treatment result if the neurotoxin is not administered to the designated skin area.

19. The method of claim 18 wherein the dermatologic agent comprises a corticosteroids emollient, wrinkle modifiers, growth factor, moisturizer, peptide, antioxidant, keratolytic agent, retinoid, deoxyribonucleic acid, acne agents, enzymes, ascorbic acid, anticellulite, glycosaminoglycans, hyaluronic acid, crossed linked hyaluronic acid or combination thereof.

20. The method of claim 18 wherein the neurotoxin is a botulinum toxin type A, B, C1, D, E, F or G.

21. The method of claim 18 wherein the neurotoxin is a botulinum toxin type A.

22. The method of claim 18 wherein the neurotoxin is administered intramuscularly, transdermally or subcutaneously.

23. A method for reducing an amount of exposure time to a dermatologic procedure during treatment of a skin condition in a human patient in need thereof, the method comprising the step of administering a neurotoxin to a skin area designated for skin treatment, thereby reducing the amount of exposure time to the dermatologic procedure to obtain a treatment result at the designated skin area,

24. The method of claim 23 wherein the dermatologic procedure comprises a varicose vein treatment, thermage treatment in facial rejuvenation procedures, filler-based treatment, high intensity focused ultrasound treatment, hormonal treatment for facial enhancement, laser treatment for hair removal, laser treatment for facial rejuvenation, tattoo removal treatments, hair removal treatment, microabrasion and dermabrasion therapies, hair loss treatment, DNA facial enhancement treatment, intense pulsed light photo rejuvenation procedures, anesthetic treatment prior to facial enhancement therapies, anticellulite treatment, facial enhancement, aesthetician treatments, massage treatment, physical and occupational therapy, chiropractic procedures, or combination thereof.

25. The method of claim 23 wherein the neurotoxin is a botulinum toxin type A, B, C1, D, E, F or G.

26. The method of claim 23 wherein the neurotoxin is a botulinum toxin type A.

27. The method of claim 23 wherein the neurotoxin is administered intramuscularly, transdermally or subcutaneously.

28. A method for treating a skin condition for a human patient in need thereof, the method comprising the steps of (a) administering a neurotoxin to a skin area designated for skin treatment,(b) determining a muscle tone at the designated skin area,(c) subjecting the designated skin area to a dermatologic agent or procedure.

29. The method of claim 28 wherein the skin treatment comprises administering a dermatologic agent.

30. The method of claim 28 wherein the skin treatment comprises administering a skin filler.

31. The method of claim 29 wherein the dermatologic agent comprises a corticosteroids emollient, wrinkle modifiers, growth factor, moisturizer, peptide, antioxidant, keratolytic agent, retinoid, deoxyribonucleic acid, acne agents, enzymes, ascorbic acid, anticellulite, glycosaminoglycans, hyaluronic acid, crossed linked hyaluronic acid or combination thereof.

32. The method of claim 28 wherein the skin treatment comprises applying a dermatologic procedure.

33. The method of claim 32 wherein the dermatologic procedure comprises a varicose vein treatment, thermage treatment in facial rejuvenation procedures, filler-based treatment, high intensity focused ultrasound treatment, hormonal treatment for facial enhancement, laser treatment for hair removal, laser treatment for facial rejuvenation, tattoo removal treatments, hair removal treatment, microabrasion and dermabrasion therapies, hair loss treatment, DNA facial enhancement treatment, intense pulsed light photo rejuvenation procedures, anesthetic treatment prior to facial enhancement therapies, anticellulite treatment, facial enhancement, aesthetician treatments, massage treatment, physical and occupational therapy, chiropractic procedures, or combination thereof.

34. The method of claim 28 wherein an amount of neurotoxin administered is inversely proportional to a degree of muscle tone.

35. The method of claim 28 wherein the neurotoxin is a botulinum toxin type A, B, C1, D, E, F or G.

36. The method of claim 28 wherein the neurotoxin is a botulinum toxin type A.

37. The method of claim 28 wherein the neurotoxin is administered intramuscularly, transdermally or subcutaneously.